Biography
Alyssa Grikscheit has a diverse corporate practice that currently emphasizes complex transactions and alternative investment funds. Her experience also includes private equity and hedge funds, mergers and acquisitions, strategic alliances and restructurings. Alyssa has extensive experience in international transactions, particularly those involving Latin America and other emerging markets such as China and India. Alyssa is fluent in Spanish and French and reads Portuguese.
Alyssa represents domestic and foreign clients making cross-border investments. She also represents buyers and sellers, including private equity funds and their portfolio companies, in acquisitions, dispositions, strategic alliances, restructurings and financings, including transactions in regulated industries such as the healthcare, pharmaceutical, energy, telecommunications and defense industries. In addition, Alyssa represents sponsors of alternative investment funds in fund formation and other aspects of their operations. Such funds have included impact, distressed debt, energy, infrastructure, real estate opportunity, agribusiness, financial inclusion and emerging market funds.
Alyssa is frequently ranked in Chambers Global, Chambers USA, and Chambers Latin America where “she is noted for her work in the M&A and private equity space and has longstanding experience dealing with cross-border transactions in Latin America.” Alyssa has been recognized by Latinvex in “Latin America’s Top 100 Lawyers” in 2015–2019 and 2021–2024 for her work throughout the region. She is recommended in Legal 500 Latin America for Corporate and M&A, most recently in its 2025 edition. Alyssa is recognized by the Latin American Corporate Counsel Association as “LACCA Approved” for Corporate and M&A. Alyssa also is highly recommended by the 2025 edition of Latin Lawyer 250. She was previously recognized in IFLR1000 as a “Rising Star” for Investment Funds in the United States.
Alyssa actively represents two nonprofit organizations in impact investing projects in emerging markets on a pro bono basis.